The present invention relates to compounds which modulate interleukin-l (IL-1 ) receptor-associated kinase 4 (IRAK4) and are useful in the prevention or treatment of inflammatory, cell proliferative and immune-related conditions and diseases. Specifically, provided herein are inhibitors of IRAK4 of Formula I and pharmaceutical compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
本发明涉及调节白细胞介素-1(IL-1)受体相关激酶4(IRAK4)的化合物,适用于预防或治疗炎症、细胞增殖和免疫相关疾病和病症。具体提供了公式I的IRAK4
抑制剂以及包含这些
抑制剂的药物组合物,以及用于治疗IRAK4介导或相关疾病或病症的方法。